Search results for: Multi-Indication Medicines
Filter search results
Ill in Europe
1 October 1982
…non-prescription medicines. They also claim health care insurance. In 1981, BUPA and other health insurance agencies paid out almost £205 million, or 1.5 per cent of the total expenditure. A…
Value-Based Pricing: OHE Comments
23 March 2011
In December 2010, the UK Department of Health released a consultation document to elicit comments on ‘proposals for a new value-based system of pricing medicines which aims to recognise and…
OHE Lunchtime Seminar: Personalised Medicine: Is it an oil-rush or oil-spill?
16 January 2020
…touted as more efficient in testing new medicines. If accepted, this will change the whole process of regulating new medicines. The seminar will also discuss how personalised medicine threatens to…
Combination Therapies: A Step Forward to the Value Attribution Problem
4 January 2023
The Policy Context An increasingly common strategy for treating many cancers is to use medicines in combination or in close sequence. However, valuing and pricing the components of a combination…
Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
16 January 2024
…company maintaining a ‘security stock’ of each product available for use in Sweden (Folkhälsomyndigheten, 2023). The model was partially delinked, with regions continuing to pay for medicines used as they…
Assessing the Value of New Antibiotics: Additional Elements of Value for Health Technology Assessment Decisions
30 May 2017
…were discussed at a multi-country, multi-disciplinary, multi-stakeholder Value Forum. Overall, there was broad agreement at the Forum that these additional elements of value were potentially relevant for HTA of new…
Time to Tackle the Challenges around Combination Therapies for Cancer
29 March 2021
…it can agree to price variations with a payer to achieve this. But, usually, different manufacturers are involved and some form of explicit multi-use pricing is required. This in turn…
Reforming Primary Health Care in Middle-Income Countries: The Good, the Bad, and the Ugly
18 July 2022
…of multiple PHC interventions under Egypt’s Health Sector Reform Program (HSRP) between 2000 and 2014. Egypt is a lower-middle-income country with a persistently high burden of out-of-pocket expenditure on health:…
Price Comparisons of Identical Products in Japan, the United States and Europe
1 August 1981
The promotion of an environment in which the multinational research-based pharmaceutical industry can flourish has been and will continue to be reliant upon a well-informed and widely-disseminated understanding of the…